Prosecution Insights
Prosecution Insights
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| Multi-statute (no §101) | 6 (86%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BALLMAN, CHRISTOPHER D | 1 | 77.1% | +20.7% |
| MELLOTT, JAMES M | 1 | 50.8% | +45.3% |
| MCCORMACK, ERIN KATHLEEN | 1 | 9.7% | +50.0% |
| SMALL, KATHERINE R | 1 | 67.9% | +30.5% |
| TOWNSLEY, SARA ELIZABETH | 1 | 25.1% | +48.8% |
| SEITZ, ANTHONY JOSEPH | 1 | 67.7% | +28.1% |
| PETERS, ALEC JON | 1 | 69.2% | +53.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18037945 | LIGHT-CONTROLLED VIRAL TRANSDUCTION | SMALL, KATHERINE R | 30d |
| 18702932 | METHOD FOR SPRAY COATING A SURFACE ATTACHED HYDROGEL | MELLOTT, JAMES M | 34d |
| 19244369 | Microvalve and Microvalve Array | BALLMAN, CHRISTOPHER D | — |
| 18277161 | METHOD AND A SENSOR FOR DETERMINING A CONCENTRATION OF A TARGET GAS IN THE BLOOD OF AN ANIMATE BEING | MCCORMACK, ERIN KATHLEEN | — |
| 18030875 | NLRP3 ACTIVATORS FOR USE IN THE TREATMENT OF INFECTIOUS DISEASES OR CANCER BY ACTIVATING NLRP3 INFLAMMASOME | TOWNSLEY, SARA ELIZABETH | — |
| 18026972 | MDM2 INHIBITORS FOR USE IN THE TREATMENT OR PREVENTION OF HEMATOLOGIC NEOPLASM RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION | SEITZ, ANTHONY JOSEPH | — |
| 17638833 | T CELL EPITOPES OF HCMV AND USES OF THEREOF | PETERS, ALEC JON | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18037945 | LIGHT-CONTROLLED VIRAL TRANSDUCTION | SMALL, KATHERINE R | 30d |
| 18702932 | METHOD FOR SPRAY COATING A SURFACE ATTACHED HYDROGEL | MELLOTT, JAMES M | 34d |
| 19244369 | Microvalve and Microvalve Array | BALLMAN, CHRISTOPHER D | — |
| 18277161 | METHOD AND A SENSOR FOR DETERMINING A CONCENTRATION OF A TARGET GAS IN THE BLOOD OF AN ANIMATE BEING | MCCORMACK, ERIN KATHLEEN | — |
| 18030875 | NLRP3 ACTIVATORS FOR USE IN THE TREATMENT OF INFECTIOUS DISEASES OR CANCER BY ACTIVATING NLRP3 INFLAMMASOME | TOWNSLEY, SARA ELIZABETH | — |
| 18026972 | MDM2 INHIBITORS FOR USE IN THE TREATMENT OR PREVENTION OF HEMATOLOGIC NEOPLASM RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION | SEITZ, ANTHONY JOSEPH | — |
| 17638833 | T CELL EPITOPES OF HCMV AND USES OF THEREOF | PETERS, ALEC JON | — |
| Art Unit | Apps |
|---|---|
| 1629 | 2 |
| 3753 | 1 |
| 1759 | 1 |
| 3791 | 1 |
| 1633 | 1 |
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19244369 | Microvalve and Microvalve Array | BALLMAN, CHRISTOPHER D | 3753 | §102§103 | Non-Final OA | — | Pending | Jun 20, 2025 |
| 18702932 | METHOD FOR SPRAY COATING A SURFACE ATTACHED HYDROGEL | MELLOTT, JAMES M | 1759 | §103§112 | Non-Final OA | 34d | Pending | Apr 19, 2024 |
| 18277161 | METHOD AND A SENSOR FOR DETERMINING A CONCENTRATION OF A TARGET GAS IN THE BLOOD OF AN ANIMATE BEING | MCCORMACK, ERIN KATHLEEN | 3791 | §103§112 | Final Rejection | — | Pending | Aug 14, 2023 |
| 18037945 | LIGHT-CONTROLLED VIRAL TRANSDUCTION | SMALL, KATHERINE R | 1633 | §101§103§112 | Final Rejection | 30d | Pending | May 19, 2023 |
| 18030875 | NLRP3 ACTIVATORS FOR USE IN THE TREATMENT OF INFECTIOUS DISEASES OR CANCER BY ACTIVATING NLRP3 INFLAMMASOME | TOWNSLEY, SARA ELIZABETH | 1629 | §102§112 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18026972 | MDM2 INHIBITORS FOR USE IN THE TREATMENT OR PREVENTION OF HEMATOLOGIC NEOPLASM RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION | SEITZ, ANTHONY JOSEPH | 1629 | §103§112 | Non-Final OA | — | Pending | Mar 17, 2023 |
| 17638833 | T CELL EPITOPES OF HCMV AND USES OF THEREOF | PETERS, ALEC JON | 1641 | §102§103§112 | Non-Final OA | — | Pending | Feb 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial